CVS Health Corporation
CVS · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $373 | $358 | $322 | $292 |
| % Growth | 4.2% | 10.9% | 10.4% | – |
| Cost of Goods Sold | $321 | $303 | $268 | $240 |
| Gross Profit | $51 | $54 | $55 | $52 |
| % Margin | 13.8% | 15.2% | 16.9% | 17.8% |
| R&D Expenses | $0 | $0 | $0 | $0 |
| G&A Expenses | $40 | $0 | $0 | $0 |
| SG&A Expenses | $41 | $0 | $0 | $0 |
| Sales & Mktg Exp. | $1 | $0 | $0 | $0 |
| Other Operating Expenses | $2 | $41 | $47 | $39 |
| Operating Expenses | $43 | $41 | $47 | $39 |
| Operating Income | $9 | $14 | $8 | $13 |
| % Margin | 2.3% | 3.8% | 2.5% | 4.6% |
| Other Income/Exp. Net | -$2 | -$3 | -$2 | -$3 |
| Pre-Tax Income | $6 | $11 | $6 | $11 |
| Tax Expense | $2 | $3 | $2 | $3 |
| Net Income | $5 | $8 | $4 | $8 |
| % Margin | 1.2% | 2.3% | 1.3% | 2.7% |
| EPS | 3.66 | 6.49 | 3.29 | 6 |
| % Growth | -43.6% | 97.3% | -45.2% | – |
| EPS Diluted | 3.66 | 6.47 | 3.26 | 5.95 |
| Weighted Avg Shares Out | 1 | 1 | 1 | 1 |
| Weighted Avg Shares Out Dil | 1 | 1 | 1 | 1 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $3 | $3 | $2 | $3 |
| Depreciation & Amortization | $5 | $4 | $4 | $4 |
| EBITDA | $14 | $18 | $12 | $18 |
| % Margin | 3.7% | 5.1% | 3.8% | 6% |